The online pipeline is undergoing construction. Please refer to this PowerPoint for most up-to-date pipeline.

View Discovery

Clinical Pipeline

Submitted for Registration Download PPT

Pre-Clinical (GLP)

Innovative Medicines for Tuberculosis (iM4TB)
Medical Centre of the University of Munich (LMU), Hans-Knöll-Institut (HKI), German Center for Infection Research (DZIF)

Phase 1

Qurient Co. Ltd. / LLC "Infectex", a portfolio firm of Maxwell Biotech Venture Fund

Phase 2

Manufacturer: Romark Laboratories
TASK Foundation NPC, GlaxoSmithKline, University Eduardo Mondlane